期刊文献+

影响重症监护病房耐碳青霉烯肠杆菌科细菌患者预后的多因素分析 被引量:2

Multivariate analysis of prognosis of carbapenem-resistant enterobacteriaceae infection patients in intensive care unit
下载PDF
导出
摘要 目的探讨影响重症监护病房(ICU)感染碳青霉烯类抗生素耐药的肠杆菌科细菌(CRE)患者预后的独立危险因素。方法回顾性收集2017年1月至2018年10月本院ICU收治的感染CRE患者147例,根据预后分为存活组(n=57)和死亡组(n=90)。单因素分析两组间的差别,Logistic回归分析影响CRE感染患者预后的的独立危险因素。结果单因素分析显示,两组患者的性别、年龄、住院时间、住ICU时间、患者来源、联用抗生素、糖尿病史、急性生理和慢性健康评分(APACHEⅡ)比较差异有统计学意义(P<0.05)。Logistic回归分析显示,住ICU时间[OR=1.088,95%CI=1.046~1.131,P=0.000]、APACHEⅡ评分(OR=1.104,95%CI=1.006~1.207,P=0.036)和糖尿病史(OR=4.047,95%CI=1.460~11.218,P=0.007)是ICU中CRE发生的独立危险因素;住院时间(OR=0.933,95%CI=0.908~0.958,P=0.000)是CRE感染患者死亡的保护因素。结论住ICU时间、住院时间、糖尿病史、APACHEⅡ评分是引起CRE医院感染患者死亡的独立影响因素。 Objective To analyze the independent risk factors of prognosis of carbapenem-resistant enterobacteriaceae(CRE)infection patients in intensive care unit(ICU),which in favour of providing scientific basis for preventing and controling CRE.Methods All the consecutive eligible patients were analyzed retrospectively from among in patients who were hospitalized from January 2017 to October 2018,147 patients were included in the study and divided into thesurvial group(n=57)and the death group(n=90)based on the resistance to prognosis.The difference between two groups were analysed used single factor analysis and the independen t risk factors were analysed used Logistic regression analysis.Results The difference of sexuality,age,length of stay,duration of ICU,survival,diabetes history,acute physiology and chronic health(APACHEⅡ)score were found between the two groups.Logistic regression analysis showed duration of ICU[OR=1.088,95%CI=1.046-1.131,P=0.000],APACHEⅡscore(OR=1.104,95%CI=1.006-1.207,P=0.036),diabetes history(OR=4.047,95%CI=1.460-11.218,P=0.007)were the independent risk factors of prognosis of CRE infection patients in ICU,and length of stay(OR=0.933,95%CI=0.908-0.958,P=0.000)was the protective factor.Conclusion Duration of ICU,length of stay,APACHEⅡscore,diabetes history were the independent influence factors of prognosis of CRE infection patients in ICU.
作者 李琼 戴新贵 王玉晶 郭伟 邓艳丽 郭立军 Li Qiong;Dai Xingui;Wang Yujing;GuoWei;Deng Yanli;Guo Lijun(Department of Critical Care,Medicine of The First People's Hospital,Chenzhou,Hunan,423000,China;Department of Neurology,Affiliated Hospital of Xiangnan University,Chenzhou,Hunan,423000,China)
出处 《当代医学》 2020年第3期1-3,共3页 Contemporary Medicine
基金 国家自然科学基金(81601708) 湘南学院校级科学研究项目(2018XJ60)
关键词 耐碳青霉烯类肠杆菌 重症监护病房 预后 多因素分析 Carbapenem-resistant enterobacteriaceae Intensive care unit Prognosis Multivariateanalysis
  • 相关文献

参考文献4

二级参考文献39

  • 1Hooi SH, Hooi ST. Culture - proven bacterial keratitis in a Malay-sian general hospital[ J ]. Med J Malaysian, 2005, 60 (5) : 614 - 623.
  • 2Yigit H, Queenan AM ,Anderson GJ, et al. Novel carbapenem - hydrolyzing beta - lactamase, KPC - 1, from a carbapenem - re- sistant strain of Klebsiella pneumoniae [ J ]. Antimicrob Agents Chemother, 2001, 45(4) : 1151 - 1161.
  • 3Bratu S, Brooks S, Burney S, et al. Detection and spread of Escherichia coli possessing the plasmid - borne carbapenemase KPC-2 in Brooklyn, New York[J]. Clin Infect Dis, 2007, 44 (7) : 972 - 975.
  • 4Clinical and Laboratory Standards Institute. Performance Standards for Antimicrebial Susceptibility Testing[S]. Twenty -Third Infor- mational Supplement, 2013, M100 - $23.
  • 5Kim BM, Jeon EJ, Jang JY, et al. Four year trend of carbapenem - resistance in newly opened ICUs of a university - affiliated hospital of South Korea[J]. Tuberc Respir Dis, 2012, 72(4): 360- 366.
  • 6Hu L, Zhong Q, Shang Y, et al. The prevalence of carbapene- mar genes and plasmid - mediated quinolone resistance determinants in carbapenem - resistant Enterobacteriaceae from five teaching hospi- tals in central China [ J ]. Epidemiol Infect, 2014, 142 ( 9 ) : 1972 - 1977.
  • 7Villa L, Feudi C, Fortini D, et al. Genomics of KPC - producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecy- cline resistance [ J]. Antimicrob Agents Chemother, 2014, 58 (3) : 1707 -1712.
  • 8Garonzik SM, Li J, Thamlikitkul V, et al. Population pharmaeo- kinetics of eolistin methanesulfonate and formed eolistin in criti- cally ill patients from a multicenter study provide dosing sugges- tions for various categories of patients [ J ]. Antimicrob Agents Chemother, 2011,55 (7) : 3284 - 3294.
  • 9Kadri SS, Hohmann SF, Orav El, et al. Tracking eolistin -trea- ted patients to monitor the incidence and outcome of earbapenem - resistant gram - negative infections [ J]. Clin Infect Dis, 2015, 60(1): 79-87.
  • 10Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem - resistant Enterobactefiaceae: a review of treatment and outcomes [ J ]. Diagn Mierobiol Infeet Dis, 2013, 75(2): 115 -120.

共引文献827

同被引文献23

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部